Date: 2018-01-17
Type of information: Nomination
Compound: vice-president
Company: Synpromics (UK)
Therapeutic area: Technology - Services
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On January 17, 2018, Synpromics, a leader in gene control, announced the appointment of Sarah Haecker Meeks to the position of Vice President, Business Development. Dr. Haecker Meeks brings a deep expertise in emerging technologies and business strategy focused on the design and development of gene medicines and will lead business development for the company.
- Synpromics has also established a new US subsidiary, Synpromics Inc. and Sarah will lead business development activities from the US covering all territories.
Financial terms:
Latest news:
Is general: Yes
